Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Irja Lutsar"'
Autor:
Arina Šablinskaja, Merit Pauskar, Ene-Ly Jõgeda, Heli Rajasaar, Pilleriin Soodla, Eveli Kallas, Anna Velts-Lindh, Ruth Küüsmaa, Kai Zilmer, Kristi Rüütel, Taavi Päll, Irja Lutsar, Kristi Huik, Radko Avi
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 33, Iss , Pp 83-88 (2023)
ABSTRACT: Objectives: In Eastern Europe, HIV-1 transmitted drug resistance (TDR) data, especially in the integrase (IN) region, are limited. In Estonia, INSTI (integrase strand transfer inhibitors) TDR has been studied only prior to the INSTI scale-u
Externí odkaz:
https://doaj.org/article/906521fcb6be4811b688b671ddd98eb4
Autor:
Taavi Päll, Aare Abroi, Radko Avi, Heiki Niglas, Arina Shablinskaja, Merit Pauskar, Ene-Ly Jõgeda, Hiie Soeorg, Eveli Kallas, Andrio Lahesaare, Kai Truusalu, Dagmar Hoidmets, Olga Sadikova, Kaspar Ratnik, Hanna Sepp, Liidia Dotsenko, Jevgenia Epštein, Heleene Suija, Katrin Kaarna, Steven Smit, Lili Milani, Mait Metspalu, Ott Eric Oopkaup, Ivar Koppel, Erik Jaaniso, Ivan Kuzmin, Heleri Inno, Uku Raudvere, Mari-Anne Härma, Paul Naaber, Tuuli Reisberg, Hedi Peterson, Ulvi Gerst Talas, Irja Lutsar, Kristi Huik
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/98d210b4fc734e4fb3099a829cd97bab
Autor:
Irja Lutsar, Tuuli Metsvaht, Sigrid Vorobjov, Ülle Parm, Annika Tiit-Vesingi, Hiie Soeorg, Jelena Štšepetova, Kai Truusalu
Publikováno v:
BMJ Paediatrics Open, Vol 7, Iss 1 (2023)
Background Hospital-acquired strains (HASs) and multiresistant strains in neonatal intensive care unit often harbour virulence and resistance mechanisms, carrying the risk of invasive infections. We describe colonisation with Enterobacteriaceae in ne
Externí odkaz:
https://doaj.org/article/978100a0189a4a9ea368b00ec3f5256a
Autor:
Katharine Cheng, Fenna Mahler, Irja Lutsar, Begonya Nafria Escalera, Stefanie Breitenstein, Gilles Vassal, Joana Claverol, Nuria Noel Palacio, Ron Portman, Gavin Pope, Martijn Bakker, Tessa van derGeest, Mark A. Turner, Saskia N. deWildt, c4c Expert Group Leads
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 3, Pp 478-488 (2023)
Abstract Many medicines are used “off‐label” in children outside the terms of the license. Feasible pediatric clinical trials are a challenge to design. Conect4children (c4c) is an Innovative Medicines Initiative project to set up a pan‐Europ
Externí odkaz:
https://doaj.org/article/c0e2c9a0347a4e119c1b97f392a17d3d
Autor:
Aare Abroi, Ulvi Gerst Talas, Merit Pauskar, Arina Shablinskaja, Tuuli Reisberg, Heiki Niglas, Taavi Päll, Mari Nelis, Ingrid Tagen, Pilleriin Soodla, Irja Lutsar, Kristi Huik
Publikováno v:
International Journal of Infectious Diseases, Vol 124, Iss , Pp 41-44 (2022)
Despite the high number of SARS-CoV-2 infections, only a few cases of dual infection have been reported. Here, we describe a case of COVID-19 caused simultaneously by Delta and Omicron variants in an immunocompetent individual during the early emerge
Externí odkaz:
https://doaj.org/article/0d095f2dda184c81be5135d4bfa312ec
Autor:
Kerstin Kase, Radko Avi, Karolin Toompere, Heli Rajasaar, Merit Pauskar, Pilleriin Soodla, Ene-Ly Jõgeda, Kai Zilmer, Irja Lutsar, Kristi Huik
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Estonia has a typical Eastern European HIV epidemic where the most frequent co-infection is chronic hepatitis C (HCV). We aimed to describe the changes in HCV prevalence, the distribution of HCV genotypes (GT), and HCV treatment i
Externí odkaz:
https://doaj.org/article/bab31ff0a3eb4518a805877255d2aa1f
Autor:
Louise F. Hill, Mark A. Turner, Irja Lutsar, Paul T. Heath, Pollyanna Hardy, Louise Linsell, Evelyne Jacqz-Aigrain, Emmanuel Roilides, Mike Sharland, for the NeoVanc Consortium
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background Vancomycin has been used in clinical practice for over 50 years; however, validated, pharmacokinetic (PK) data relating clinical outcomes to different dosing regimens in neonates are lacking. Coagulase negative staphylococci (CoNS
Externí odkaz:
https://doaj.org/article/9eea61471cbd4c9b941d7f02f42ad8b9
Autor:
Petter I. Andersen, Aleksandr Ianevski, Hilde Lysvand, Astra Vitkauskiene, Valentyn Oksenych, Magnar Bjørås, Kaidi Telling, Irja Lutsar, Uga Dumpis, Yasuhiko Irie, Tanel Tenson, Anu Kantele, Denis E. Kainov
Publikováno v:
International Journal of Infectious Diseases, Vol 93, Iss , Pp 268-276 (2020)
Viral diseases are one of the leading causes of morbidity and mortality in the world. Virus-specific vaccines and antiviral drugs are the most powerful tools to combat viral diseases. However, broad-spectrum antiviral agents (BSAAs, i.e. compounds ta
Externí odkaz:
https://doaj.org/article/b7df612e248149ccadb4f15ffc07957d
Autor:
Liina Tserel, Piia Jõgi, Paul Naaber, Julia Maslovskaja, Annika Häling, Ahto Salumets, Eva Zusinaite, Hiie Soeorg, Freddy Lättekivi, Diana Ingerainen, Mari Soots, Karolin Toompere, Katrin Kaarna, Kai Kisand, Irja Lutsar, Pärt Peterson
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The clinical features of SARS-CoV-2 infection range from asymptomatic to severe disease with life-threatening complications. Understanding the persistence of immune responses in asymptomatic individuals merit special attention because of their import
Externí odkaz:
https://doaj.org/article/16d58d8a765443ca94de79c1eecf2447
Autor:
Irja Lutsar, Corine Chazallon, Ursula Trafojer, Vincent Meiffredy de Cabre, Cinzia Auriti, Chiara Bertaina, Francesca Ippolita Calo Carducci, Fuat Emre Canpolat, Susanna Esposito, Isabelle Fournier, Maarja Hallik, Paul T Heath, Mari-Liis Ilmoja, Elias Iosifidis, Jelena Kuznetsova, Laurence Meyer, Tuuli Metsvaht, George Mitsiakos, Zoi Dorothea Pana, Fabio Mosca, Lorenza Pugni, Emmanuel Roilides, Paolo Rossi, Kosmas Sarafidis, Laura Sanchez, Michael Sharland, Vytautas Usonis, Adilia Warris, Jean-Pierre Aboulker, Carlo Giaquinto, NeoMero Consortium
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229380 (2020)
BackgroundThe early use of broad-spectrum antibiotics remains the cornerstone for the treatment of neonatal late onset sepsis (LOS). However, which antibiotics should be used is still debatable, as relevant studies were conducted more than 20 years a
Externí odkaz:
https://doaj.org/article/5bc7b37463974d8097f65fa5ce50f0e2